patent-istock-579425600-duncan-andison
Duncan_Andison / iStockphoto.com
7 March 2017Americas

PTAB denies Celltrion’s patent challenge against Genentech

The Patent Trial and Appeal Board (PTAB) has rejected Celltrion’s challenge against a Genentech patent centring on a method of treating rheumatoid arthritis, stating that the challenged patent did not show any reasonable likelihood of being invalid.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
31 October 2017   The Patent Trial and Appeal Board has agreed to rehear an inter partes review (IPR) filed by Hospira, a company now owned by Pfizer.